Pituitary adenylate cyclase-activating polypeptide (PACAP) is an important hypophysiotrophic factor as well as a regulator for immune, reproductive and neural tissues. Transcription of the PACAP gene is known to be regulated by several well-known transcription factors such as the cAMP response element binding protein, but no specific transcription factor for PACAP gene expression has thus far been reported.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is an important hypophysiotrophic factor as well as a regulator for immune, reproductive and neural tissues. Transcription of the PACAP gene is known to be regulated by several well-known transcription factors such as the cAMP response element binding protein, but no specific transcription factor for PACAP gene expression has thus far been reported.
We recently found that TTF-1, a homeodomain-containing transcription factor essential for the development of the fetal diencephalon, is postnatally expressed in the hypothalamic area and plays a transcription-regulatory role for certain neurohormones, including luteinizing hormone-releasing hormone.
Based on the similarity of synthesis sites between PACAP and TTF-1, and moreover, on the presence of conserved core TTF-1 binding motifs in the 5'-flanking region of the PACAP gene, we sought to uncover a regulatory role of TTF-1 in PACAP gene transcription. The TTF-1 homeodomain binds to 6 of the 7 putative binding domains observed in the 5'-flanking region of the PACAP gene. In the C6 glioma cellline, TTF-1 activates the PACAP promoter in a dose-dependent manner. This transactivation of PACAP by TTF-1 was totally removed when the core TTF-1 binding motif at -369 was deleted. RNase protection assays showed that TTF-1 and PACAP mRNAs have daily fluctuations in the rat hypothalamus. They both were at low levels during the day and high levels during the night. TTF-1 mRNA showed a peak level at 2100 h, 2 h after lights off and the PACAP mRNA peak followed this 3 h later. Icv administration of an antisense TTF-1 oligodeoxynucleotide significantly decreased the PACAP mRNA level as well as TTF-1 protein content in the rat hypothalamus, suggesting that TTF-1 also regulates PACAP transcription in vivo. Moreover, the TTF-1 promoter was inhibited by molecular oscillators of CLOCK and BMAL-1.
EXPERIMENTAL PROCEDURES

Primer Extension for PACAP Transcription Initiation Site Determination
To ascertain the transcription initiation site of the PACAP gene, primer extension of mRNA samples from the rat brain was employed. A 32-base oligonucleotide primer (5'-CTTCTCTGCTCCGAGGT CTCAGGCTGAGTCTG-3') complementary to the nucleotides within exon1A of the rat PACAP gene (7) was end-labeled with γ-[ C for 90 min. After the mixture was slowly cooled to room temperature, the hybridized mRNA was reverse-transcribed at 42 o C for 1 h using the MMLV reverse transcriptase (Invitrogen). The extended cDNA products were extracted and separated on a 6 % denaturing polyacrylamide gel. The length of the formed products was determined by comparison to sequencing reactions carried out on genomic clones using the same primer in parallel.
Electrophoretic Mobility Shift Assay (EMSA)
The procedure for expression and purification of the TTF-1 homeodomain (TTF-1HD) has already been described (15) . Double-stranded oligodeoxynucleotides, labeled at the 5' end terminal with 32 P, were used as probes for the EMSA. Sequences of the oligonucleotides used are shown in Table 1 . Oligonucleotides C and Cβ were used as a positive and negative control, respectively (16) . EMSA was performed by incubating, for 30 min at room temperature, proteins and DNA in a buffer containing 20 mM Tris-HCl pH 7.6, 75 mM KCl , 0.25 mg/ml bovine serum albumin (BSA), 5 mM dithiothreitol (DTT), 12.5 µg/ml calf to the protein-bound and free DNA were quantitated by using Multi-analyst software. Binding of TTF-1HD to oligonucleotides of the PACAP promoter was expressed as a percentage of the TTF-1HD binding to oligonucleotide C.
Serial Deletion of the PACAP Promoter and Site-Directed Deletion of TTF-1 Binding Core Motifs
The rat PACAP-promoter, luciferase reporter (pGL3-basic) vector was previously described (7). Serial deletion from this promoter was produced with restriction enzymes that cut uniquely in the promoter at the 5'-end (Pst I for -1007, Bxt I for -708, Xba I for -481, and Aat II for -199) and with Spe I of the vector's multicloning site at the 3'-end. These truncated promoters were inserted into the pGL3-basic vector at each corresponding restriction enzyme site within the multicloning site. Promoter constructs containing more detailed deletions between -481 and -199 were generated by PCR reactions with specific primer sets corresponding to the -414, -384, -314 and -267 bp of promoter sequences at the 5'-end, and with a specific primer for a Spe I site in the multicloning site of the pGL-3-basic vector at the 3'-end. Site-specific deletions of core binding motifs for TTF-1 were created with two rounds of PCR reactions. The first-round was performed to generate upstream fragments before the core binding motifs, with an RV3 primer in the pGL3-basic vector and a specific primer placed upstream of each core motif.
Downstream fragments of the core motifs were amplified with a specific primer placed downstream, and the GL2 primer placed in the pGL3-basic vector. The second-round of PCR was performed with a specific nested-primer set inside the span between RV3 and GL2 to link the upstream and downstream fragments.
These deletion mutants were cloned into the pGL-3-basic vector.
Cell Culture and Assays for Luciferase and SEAP Activity
C6 cells were grown in DMEM: F12 (Sigma) containing 10% fetal bovine serum (FBS); NIH3T3 cells were cultured in DMEM, containing high glucose (4.5 g/l, 25 mM), supplemented with 10% FBS.
PACAP promoter analysis employed the C6 cells. Twenty-four hours after seeding the cells in six-well plates, they were transiently transfected with a PACAP-promoter, luciferase-reporter construct (PACAPpGL3) using Lipofectamine (Invitrogen), along with different concentrations (100 -400 ng/ml) of the TTF-1 expression vector (TTF-1-pcDNA zeo). A TTF-1-promoter, luciferase-reporter vector (TTF-1-pGL2) was cotransfected into NIH3T3 cells with expression vectors containing CLOCK (CLOCKpcDNA zeo) and BMAL1 (BMAL1-pcDNA zeo). Transfection efficiency was normalized by cotransfecting the plasmid pCMV-β-gal (Clontech) at 20 ng/ml. The total amount of DNA transfected was kept constant at 800 ng/ml by adding the appropriate amount of pcDNA zeo to each well. The transfected cells were harvested 48 h after transfection for luciferase and β-galactosidase assays as reported (8) . For the SEAP activity assay, medium from cells transfected with the PACAP-promoter-SEAP reporter vector (PACAP-SEAP) was collected 48 h after transfection at 3 h intervals for 24 h. Chemiluminescence detection of SEAP activity was performed according to the manufacturer (Clontech) using Hyper-Film β-Max (Amersham Biosciences) exposed to the base of a 96-well plate.
Animals and Tissue Preparation
Two-month-old male Sprague-Dawley rats (Daehan Animal Breeding Company, Chungwon, Chungbuk, South Korea) were used in this study. They were housed in a room with a conditioned photoperiod (12 h light/12 h darkness, lights on from 0700 -1900 h) and temperature (23 -25 o C) just after arrival and allowed ad libitum access to tap water and pelleted rat chow. Animals were sacrificed at 3 h intervals for one day, their brains removed and the hypothalamus, including the POA and MBH, were collected. The tissues were quickly frozen on dry ice, and stored at -85 o C until RNA isolation.
Total RNA was isolated as reported (17) ; the RPA employed has been described in detail (18) ; and the preparation of antisense RNA probes for TTF-1, PACAP and cyclophilin (Cyclo, the internal control), followed a described procedure (8, 19, 20) . RNA samples (5 µg/tube) or different amounts of in vitrosynthesized TTF-1 and PACAP sense mRNA (0.03-2 pg/tube) were hybridized to 500,000 cpm of 32 Plabeled TTF-1 and PACAP cRNA probes, respectively, for 18-20 h at 45 o C. The tissue RNA samples were simultaneously hybridized to a Cyclo cRNA probe (5,000 cpm/tube) to correct for procedural losses (18) .
At the end of the hybridization, the samples were treated with ribonucleases A and T1 to digest unhybridized RNA species. The protected cRNA fragments were separated on a polyacrylamide-urea gel (5% acrylamide, 7 M urea), and the hybridization signals were detected by exposure of the dried gels to X-Omat X-ray film (Amersham Biosciences). The intensity of the signals obtained was quantified as
reported (18), using an edited version of the Image program (21) .
Icv Administration of Antisense (AS) TTF-1 Oligodeoxynucleotide (ODN)
To determine the inhibitory effect of TTF-1 synthesis on PACAP mRNA levels, phosphorothioate AS (20) . After a week of recovery, the inner stylet was removed and the ODNs (2 nmol in ACSF)
were icv-injected with a Hamilton syringe once a day for 2 consecutive days. The animals were sacrificed at 2400 h (5 h after lights off) on the day following the second ODN administration. Total RNA from most animals or nuclear proteins from some animals were extracted from the hypothalamus.
Western Blot Analysis of TTF-1 Protein
Nuclear protein extracts were prepared according to the method of Andrews and Faller (22) to the supplied protocol. The membranes were exposed to the X-ray film for 3 min in the dark room.
Statistics
Changes in TTF-1 and PACAP mRNA levels and SEAP-assay data were analyzed by a one-way analysis of variance followed by the Student Neuman-Keuls multiple comparison test for unequal replications.
Changes observed between two groups were analyzed by student's t-test.
RESULTS
Transcriptional Start Site of PACAP Gene
To identify the transcriptional start site of the rat PACAP gene, we performed the primer extension procedure using mRNA from rat hypothalamus. Primer extension showed a single transcriptional start site of the rat PACAP gene located upstream of the translation initiation site ( Fig. 1 and 2 ). Primer extension with the rat hypothalamic mRNA terminated at the G according to a concomitant sequence analysis, while no specific reaction was observed with mRNA from a plant ( Fig. 1 ). Utilizing this result, a single transcriptional start site was mapped at -61 bp, which is also indicated in Fig. 2 .
Identification of Consensus TTF-1 Binding Motifs in the Rat PACAP Promoter
To 
TTF-1 Binds to the Putative Binding Domains in the 5'-Flanking Region of PACAP gene
EMSAs were performed to examine TTF-1HD binding to the putative TTF-1 binding domains utilizing double stranded oligodeoxynucleotide probes (Table 1) Fig. 2 and 3) . A deletion reaching to -199 resulted in a loss of PACAP transactivation by TTF-1, therefore this promoter region has basic essential TTF-1 transactivation motifs; this region has 2 TTF-1 binding core motifs at -369 and -220 ( Fig. 2 and 3 ).
Further deletions between -481 to -199 revealed the essential promoter sequence for the transactivation of PACAP gene by TTF-1 (Fig. 4B) . A deletion between -384 to -314 completely abolished TTF-1 transactivation of the PACAP promoter. There is a TTF-1 binding motif at -369 (CTTG), therefore, this sequence seems to be basically critical for TTF-1 transactivation of the PACAP promoter.
Loss of PACAP Transactivation by TTF-1 after Deletion of the TTF-1 Binding Core Motif at -369 bp
Based on the described promoter assay, the sequence placed at -369 appears to be critical for basic transactivation of PACAP by TTF-1, though it showed a very weak binding affinity with TTF-1HD compared to others (Fig. 3) . To confirm that this site is essential for the PACAP transactivation by TTF-1, 6 core motifs (including -369) were site-specifically deleted and promoter analyses were performed with these mutated PACAP promoters. TTF-1-dependent transactivation of the PACAP promoter completely disappeared without the core motif at -369 ( Fig. 5) , further confirming that the binding motif at -369 is essential. Deletions of core motifs at -494, -1318 and -100 resulted in a decrease of PACAP promoter activation by TTF-1 compared to the wild promoter construct, suggesting that these motifs also play an important role in TTF-1 transactivation of PACAP in addition to the basic essential function of that at -369.
Continuous Analysis of PACAP Promoter Activation Induced by TTF-1
Changes in PACAP promoter activity in C6 cells were continuously monitored for 24 h, using the SEAP reporter vector system, in the presence or absence of the TTF-1 expression vector (Fig. 6A) . The PACAP basic promoter activity --without using the TTF-1 expression vector --showed continuous changes during a 24 h time period with 2 peaks of activity (Fig. 6B) . The peak amplitudes were highly enhanced, without any increase in basal activity, by adding the TTF-1 expression vector. The fluctuation of basal PACAP promoter activity, during a 24 h incubation time, suggests that PACAP transcription has an endogenous rhythm in C6 cells that can be amplified by TTF-1. We tried therefore, to determine what daily changes there were within the rat hypothalamus in TTF-1 and PACAP mRNA levels during a normal 12-h-day and 12-h-night cycle.
Daily Changes of TTF-1 and PACAP mRNA Levels in the Rat Hypothalamus
TTF-1 and PACAP mRNA levels in the 2-month-old male rat hypothalamus were simultaneously determined by single RPAs (Fig. 7) . The densities of autoradiographic bands were normalized to those of the Cyclo internal control probe and calculated by comparison to standard curves generated with sense RNAs (data not shown). Representative results of the RPAs are shown in Fig. 7A . Generally, TTF-1 and PACAP mRNA levels are low during the day and high at night. The mean PACAP mRNA level during the night is significantly higher than that during day. Specifically, the TTF-1 mRNA level showed its peak at 2100 h, 2 h after lights off, and the PACAP mRNA level peaked at 2400 h, 3 h after TTF-1 ( Fig. 7B and   7C ).
Effect of the AS TTF-1 ODN on PACAP mRNA Levels in the Hypothalamus
To determine the in vivo effect of TTF-1-synthesis inhibition on PACAP mRNA levels, AS TTF-1 ODN was injected into the ventral region of the third ventricle of 2-month-old male rats. One day after an AS ODN injection/day, for 2 consecutive days, RNA extracted from hypothalamus was used in an RPA. To validate the specific action of AS TTF-1 ODN on the TTF-1 protein level, nuclear protein from the AS TTF-1 ODN-injected rat hypothalami was analyzed with Western blots using a TTF-1 antibody. This antibody detected the expected 40 kDa band of TTF-1 protein (Fig. 8A) . The TTF-1 AS ODN clearly decreased the density of TTF-1-specific bands in Western blots compared to samples from SCR ODNinjected and sham-operated animals (Fig. 8B) . The AS ODN also significantly decreased PACAP mRNA levels as determined by RPA (Fig. 8C) , suggesting that TTF-1 plays a transactivational role in PACAP mRNA expression in vivo as well as in C6 cells. This ODN also decreased TTF-1 mRNA levels which were assessed along with PACAP mRNA (data not shown).
Clock Genes Inhibit TTF-1 Transcription
The enhancement by TTF-1 of PACAP transcription and its mRNA level, both in vivo and in vitro as . The basal production of PACAP has been known to be constitutive, but is also enhanced by a cAMP analog, TPA, or by PACAP-38 itself (27) . Moreover, the mouse PACAP promoter-luciferase reporter fusion gene was greatly stimulated by forskolin and PACAP-38, suggesting that the induction of PACAP expression by these factors occurs at the transcriptional level (6) . The presence of PRE in the distal promoter region supports our earlier finding that progesterone increases the PACAP mRNA level of rat hypothalamus (20) .
Previously we found several putative down-stream target genes for TTF-1 such as luteinizing hormone-releasing hormone, the neuregulin receptor erbB-2 and preproenkephalin, based on the conserved TTF-1 binding motifs in their promoter sequences and the similarity of their synthesis site with TTF-1 (8). All the above promoters bearing a conserved TTF-1 binding motif were regulated by TTF-1.
This approach has again proven to be effective in the present study of PACAP transactivation by TTF-1.
Because the high affinity TTF-1 binding domain is strictly conserved in its target genes (14, 15, 28 ) and the 5'-flanking region of PACAP gene has 7 conserved TTF-1 binding motif-like sequences, we assayed TTF-1 binding activity to these 7 sites. Among them, six showed binding activity to TTF-1HD, and of these 6, motifs at -1318, -1303 and -100 showed the strongest binding activity; the others bound more weakly. However, the promoter assay with the deletion mutants showed that the sequence at -369, which (Fig. 2) . F2F is believed to play a role as a tissue-specific inhibitory regulator for prolactin gene transcription (24) , and further study will elucidate its role in PACAP transcriptional regulation. Thus, this kind of peripheral rhythm generation appears to be dependent upon neural or humoral circadian inputs originally generated in the SCN.
PACAP is a pleiotropic peptide, having numerous actions in the central nervous system and peripheral organs (31) , and one of its recently identified functions is the modulation of circadian activity. Photic cues are transmitted to the SCN via the retinohypothalamic tract (RHT) (32) , and entrains the SCN and its output rhythms to a 24 h day cycle. PACAP is abundant in the rat SCN, the RHT and retinal ganglionic cells (32, 33) , and has been shown to reset the circadian clock in a manner similar to light (34, 35) . Taken together, these reports suggest an involvement of PACAP in the regulation of central circadian rhythm in the mammalian SCN.
No clear evidence for transcriptional regulation of PACAP in the RHT and hypothalamus has yet been reported, however. The present data suggest that TTF-1 not only plays a role in the transcriptional regulation of PACAP, but is also involved in the mediation of the daily rhythm of its gene expression.
Daily variation of PACAP content was demonstrated in the SCN itself, and moreover, a similar pattern was also observed in the periventricular nucleus and cerebral cortex, although the overall change was not significant in these latter two regions (36) . The daily PACAP mRNA changes found in the present study looks similar to that of its protein levels (36) , and also shows similarity with already reported daily changes in PACAP receptor mRNA in the SCN and SON (37) . Interestingly, our present report of the daily changes in PACAP promoter activity -as determined with SEAP assays -which showed 2 peaks, is very similar with the reported daily change pattern of PACAP receptor mRNA in the SCN and SON (37), as well as the PACAP content in the cerebral cortex (36) . While the ramifications for these similarities are unclear, they suggest that similar mechanisms are involved in PACAP synthesis.
Circadian rhythms generated in the SCN -that secondarily regulate rhythms in other nuclei of hypothalamus, via the release of several factors including arginine vasopressin and VIP (38) Bd, protein-bound DNA; F, free DNA. The data are means ± SEM of 6 wells per each construct. A T G C R a t b r a i n P l a n t 
